Assessing Novo Nordisk (CPSE:NOVO B) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Recent performance context for Novo Nordisk Novo Nordisk (CPSE:NOVO B) has drawn investor attention after a period where the share price shows a 0.8% one day decline and mixed returns over the past week, month, and past 3 months. With a market value around DKK 1,043.5b and annual revenue of DKK 309.1b, the company continues to be a large presence in global diabetes, obesity care, and rare disease treatments. See our latest analysis for Novo Nordisk. At a DKK235.1 share price, recent moves tell a mixed story, with a 1-week share price return of 1.82% set against a 90-day share price return decline of 35.84% and a 1-year total shareholder return decline of 43.33%. If this kind of volatility has you looking beyond a single name, it could be a useful moment to broaden your watchlist with 127 healthcare AI stocks With the share price well below some valuation estimates yet coming off a long period of strong gains, the key question is simple: is Novo Nordisk now trading at a di
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- CNBC's UK Exchange newsletter: Brace yourself for rising bills as new tax year kicks off Share [CNBC]CNBC
- Vltava Fund Q1 2026 Letter To Shareholders [Seeking Alpha]Seeking Alpha
- Weight-loss pills draw first-time GLP-1 users with lower cost, ease [USA TODAY]USA TODAY
- Hims & Hers says limited data stolen in social engineering attack [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk: Downgrading To 'Sell' As GLP-1 Pipeline Faces Many Risks [Seeking Alpha]Seeking Alpha
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 4/7/26 - Form 6-K
- 3/30/26 - Form 6-K
- 3/27/26 - Form 6-K
- NVO's page on the SEC website